Stock Analysis - Tryg
Image Source: Unsplash
TVGSY was founded in January 2002 and is headquartered in Ballerup, Denmark.
Tryg A/S provides insurance services. It operates through the following segments: Private, Commercial, Corporate and Other.
Three key data points gauge TVGSY (or any dividend paying entity):
(1) Price
(2) Dividends
(3) Returns
Those three keys also indicate if any company has made, is making, and will make money.
TVGSY Price
Tryg A/S’s single share price declined $1.32 (or 20%) from $6.32 to $5.00 this past year, per Wednesday’s market report.
No analysts cover the stock.This is the first price decline in 5 year of stock history,
TVGSY Dividends
TVGSY has declared and paid quarterly dividends since May 2021.
The February 2026 Q dividend of $0.06 suggests $0.24 annual dividend for the coming year.
TVGSY Returns
Putting it all together, a hypothetical annual gross gain of $0.24 per share is predicted by adding the $0.24 forward-looking dividend to no annual price-gain.
A little over $1000 invested at Monday’s $5.00 share price would buy 200 shares which multiply the $0.24 dividend gain to an estimated $48.00 upside for the coming year.
100% of that $48.00 upside gain could come from the $48.00 annual dividend payout from your $1,000 investment.
And the $48.00 dividend from $1k invested is 9.6 times more than TVGSY’s $5.00 single share price.
(A dividend dogcatcher rule is to only buy initial shares of a stock that pay an annual dividend from $1000 invested that is greater than the cost of a single share.)
TVGSY’s forthcoming dividend from $1,000 invested is about 9.6X more the price of a single share.
The exact track of TGVSY’s future share price and dividend will entirely be determined by market action and company finances.
Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.
More By This Author:
Current Report: LCNB
Current Report: Fubon Financial
Stock Analysis: Weibo
Disclaimer: This article is provided as a suggestion for further research It is not a recommendation nor an endorsement of the company or any of its subsidiaries. There is no reason ...
more